| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |